Texas 2025 - 89th Regular

Texas Senate Bill SB1044

Filed
1/31/25  
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to newborn screening tests for Duchenne muscular dystrophy.

Impact

The enactment of SB1044 would significantly alter state healthcare practices regarding newborn screenings. By incorporating DMD into existing screening programs, the bill emphasizes the importance of early detection, thereby enabling timely interventions that can improve the quality of life for affected individuals. Consequently, this measure is poised to foster better health outcomes for children, reduce long-term healthcare costs, and enhance overall public health initiatives focusing on congenital disorders.

Summary

SB1044 is a legislative proposal aimed at improving the early detection and management of Duchenne muscular dystrophy (DMD) through mandated newborn screening tests in Texas. The bill amends the Health and Safety Code to include DMD within the framework of heritable diseases that are subject to screening requirements. By requiring healthcare providers to conduct these screenings on newborns, the bill seeks to mitigate the adverse health outcomes associated with late diagnosis of this progressive muscular degeneration disorder.

Sentiment

The general sentiment surrounding SB1044 appears to be positive, as many stakeholders, including healthcare professionals and advocacy groups for muscular dystrophy, support the need for early screening. Proponents argue that early diagnosis can lead to more effective treatments and improved management of the disease. However, discussions in committee hearings indicate some concerns about resource allocation and the funding necessary to implement these new screening requirements effectively.

Contention

Notable points of contention include the fiscal implications of expanding the newborn screening program and the need for adequate funding from the legislature to support the bill's implementation. Critics raise concerns that without proper financial backing, the program may struggle to meet its objectives, potentially undermining its effectiveness. Moreover, there may be discussions regarding the technical feasibility of detecting DMD alongside other mandated screenings, highlighting the need for robust training and resources for healthcare providers.

Texas Constitutional Statutes Affected

Health And Safety Code

  • Chapter 33. Phenylketonuria, Other Heritable Diseases, Hypothyroidism, And Certain Other Disorders
    • Section: New Section
    • Section: 014
    • Section: 031
    • Section: 032
    • Section: New Section
    • Section: 014
    • Section: 031
    • Section: 032
    • Section: New Section
    • Section: 014
    • Section: 031
    • Section: 032

Occupations Code

  • Chapter 203. Midwives
    • Section: 355
    • Section: 355
    • Section: 355

Companion Bills

TX HB2295

Identical Relating to newborn screening tests for Duchenne muscular dystrophy.

Similar Bills

TX HB2295

Relating to newborn screening tests for Duchenne muscular dystrophy.

IL SB2261

$IDPH-MUSCULAR DYSTROPHY

CT HB06573

An Act Requiring Newborn Screening For Duchenne Muscular Dystrophy.

CT HB05710

An Act Requiring Newborn Screening For Duchenne Muscular Dystrophy.

AZ SB1076

Newborn screening; Duchenne muscular dystrophy

CT HB06919

An Act Requiring Newborn Screening For Duchenne Muscular Dystrophy.

AR HB1302

To Add Duchenne Muscular Dystrophy To The Universal Newborn Screening Act.

TX SB1667

Relating to newborn screening.